New Cancer Drug May Skip Ireland

A new cancer drug by Bristol Myers Squibb may not be available in Ireland.

By Olivia O’Mahony, Editorial Assistant
August / September 2016

A groundbreaking new melanoma treatment is being rolled out to patients in the U.K., but may never reach those in Ireland. The National Pharmacoeconomics Centre (NCPE), an independent medicine cost advisory board, has recommended that the HSE does not make the Opdivo drug available through the public system due to uncertainty about its financial sustainability.

Research has proven that melanoma patients have a substantially longer life expectancy when taking Opdivo, which, unlike conventional chemotherapy, is administered by a drip. The drug was developed by Bristol Myers Squib, who told the NCPE that Opdivo’s net cost over the first five years will come to €17.6 million. This estimation is based on the drug’s usage being capped at a maximum of two years. However, the NCPE review group found insufficient evidence that the projected discontinuation point would hold true. Even following a revised gross budget submission from Bristol Myers Squib in 2015, the NCPE did not consider Opdivo cost-effective.

A spokeswoman for the HSE said that it was required to manage financial provisions for new medicines in a fair manner, with access being made available to as wide a range of new drugs as sustainably possible.

Opdivo will be reviewed by the National Cancer Control Program Technology Review Committee. If given a positive recommendation, it will be sent to the HSE Drugs Committee for the ultimate ruling on its funding. ♦

One Response to “New Cancer Drug May Skip Ireland”

  1. Margaret Clifford says:

    Very disappointed to read this article because this could have a future affect on out family!!!!

Leave a Reply




Share



More Articles

Joe Biden Opens Irish Hospice

Former U.S. Vice President Joe Biden visited County Mayo in September to preside over the official sod-turning ceremony...

More

Medical Breakthroughs that Matter

Irish universities are leading the way in breakthrough medical science.  ℘℘℘ Testing Breakthroughs at...

More

HIV on the Rise in Ireland

Recent figures from the Health Protection Surveillance Centre, Ireland’s specialist agency for the surveillance of...

More

UCD Honors Medicine Alumnus and U.N. Peacekeeper

Dr. Patrick Kelly (pictured above with Jamie Merisotis​,​ president and CEO of the Lumina Foundation) received an...

More